MOMI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 2.175
AS - Asia 1.582
EU - Europa 1.501
SA - Sud America 251
Continente sconosciuto - Info sul continente non disponibili 119
AF - Africa 36
OC - Oceania 1
Totale 5.665
Nazione #
US - Stati Uniti d'America 2.129
SG - Singapore 700
IE - Irlanda 271
UA - Ucraina 250
IT - Italia 238
CN - Cina 225
RU - Federazione Russa 212
HK - Hong Kong 202
VN - Vietnam 197
BR - Brasile 190
SE - Svezia 123
DE - Germania 104
FR - Francia 84
FI - Finlandia 82
BD - Bangladesh 60
GB - Regno Unito 56
KR - Corea 40
TR - Turchia 32
IN - India 28
CA - Canada 26
AR - Argentina 24
PK - Pakistan 13
CO - Colombia 12
ES - Italia 12
UZ - Uzbekistan 12
ZA - Sudafrica 10
BE - Belgio 9
IQ - Iraq 9
MX - Messico 9
AT - Austria 8
CH - Svizzera 8
JP - Giappone 8
MA - Marocco 8
NL - Olanda 8
PL - Polonia 7
EC - Ecuador 6
LB - Libano 6
VE - Venezuela 6
CL - Cile 5
ID - Indonesia 5
IR - Iran 5
JO - Giordania 5
MY - Malesia 5
PH - Filippine 5
RO - Romania 5
CZ - Repubblica Ceca 4
IL - Israele 4
KE - Kenya 4
PE - Perù 4
SA - Arabia Saudita 4
KZ - Kazakistan 3
LT - Lituania 3
NP - Nepal 3
SN - Senegal 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
DZ - Algeria 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
PA - Panama 2
PR - Porto Rico 2
RS - Serbia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
Totale 5.548
Città #
Singapore 494
Chandler 326
Dublin 266
Hong Kong 201
San Jose 174
San Mateo 146
Jacksonville 139
Ashburn 107
Santa Clara 90
Dong Ket 83
Boardman 80
Perugia 79
Altamura 77
Beijing 75
Medford 63
Princeton 63
Moscow 60
Lawrence 57
Lauterbourg 52
Ann Arbor 51
Wilmington 51
New York 42
Seoul 39
Ho Chi Minh City 37
Los Angeles 34
Andover 29
Hanoi 28
Des Moines 27
Munich 27
The Dalles 27
Saint Petersburg 21
São Paulo 21
Piscataway 20
Helsinki 18
Dearborn 17
Frankfurt am Main 15
San Paolo di Civitate 12
Woodbridge 12
Brooklyn 11
Dallas 11
Izmir 11
Norwalk 10
Shanghai 10
Turku 10
Brussels 9
Da Nang 9
London 9
Falkenstein 8
Johannesburg 8
Phoenix 8
Tokyo 8
Ankara 7
Orem 7
Rome 7
Stockholm 7
Toronto 7
Denver 6
Houston 6
Madrid 6
Nuremberg 6
Poplar 6
San Francisco 6
Tashkent 6
Baghdad 5
Belo Horizonte 5
Buffalo 5
Columbus 5
Curitiba 5
Montreal 5
New Delhi 5
Ottawa 5
Amsterdam 4
Atlanta 4
Auburn Hills 4
Bogotá 4
Campo Grande 4
Charlotte 4
Chennai 4
Delhi 4
Falls Church 4
Haiphong 4
Lahore 4
Medellín 4
Milan 4
Olomouc 4
Roubaix 4
Santo André 4
Amelia 3
Amman 3
Aracaju 3
Bắc Ninh 3
Can Tho 3
Dakar 3
Guayaquil 3
Hải Dương 3
Islamabad 3
Istanbul 3
Kuala Lumpur 3
Lima 3
Menlo Park 3
Totale 3.502
Nome #
Reperfusion of cerebral artery thrombosis by the GPIb-VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs. 140
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 134
Nitric oxide and its antithrombotic action on the cardiovascular system 130
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation. No effect of aspirin intake. 129
Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. 126
Platelets are essential for leukocyte recruitment in allergic inflammation. 126
A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling 120
Allergen induces the migration of platelets to lung tissue in allergic asthma. 117
Defective platelet beta-N-Acetyl hexosaminidase content and release in chronic myeloproliferative disorders 115
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 113
RhoA signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice. 112
Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation 112
A novel nitric oxide-releasing statin derivative exerts and antiplatelet/antithrombotic activity and inhibits tissue factor expression. 112
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 110
AB0952 Intra-articular low molecular weight hyaluronate reduces platelet influx and matrix metalloproteinase-2 levels in synovial fluid of patients with knee osteoarthritis 110
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives. 109
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 109
Anti-platelet therapy: phosphodiesterase inhibitors. 106
Anti-platelet treatments in cancer: Basic and clinical research 105
Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. 104
A dichotomy in platelet activation: Evidence of different functional platelet responses to inflammatory versus haemostatic stimuli 104
Platelets contribute to the accumulation of matrix metalloproteinase type 2 in synovial fluid in osteoarthritis 103
Prevalence of hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage 97
Matrix metalloproteinases and peripheral arterial disease. 95
Established and new antiplatelet therapies 93
Matrix metalloproteinase-2 enhances platelet deposition on collagen under flow conditions 92
Matrix metalloproteinase-2 of human carotid atherosclerotic plaques promotes platelet activation. Correlation with ischaemic events. 91
Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome. 91
Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation. 89
Highly Active Antiretroviral Therapy-related Mechanisms of Endothelial and Platelets Function Alterations 88
HYPERGLYCEMIA-INDUCED PLATELET ACTIVATION IN TYPE 2 DIABETES MELLITUS IS RESISTANT TO ASPIRIN BUT NOT TO A NITRIC OXIDE-DONATING AGENT. 88
Endothelium, venous thromboembolism and ischaemic cardiovascular events. 87
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression. 85
Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders. 85
Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice 84
Chemotaxis and phagocytosis 84
Visualization of nitric oxide production by individual platelets during adhesion in flowing blood. 84
Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin. 82
Platelet-targeted pharmacologic treatments as anti-cancer therapy 82
Platelet Priming. 79
Nitric oxide-enhancing or -releasing agents as antithrombotic drugs. 79
Impaired thrombin-induced platelet activation and thrombus formation in mice lacking the Ca(2+)-dependent tyrosine kinase Pyk2. 78
Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature. 77
Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition. 76
Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. 75
NCX4016: a novel antithrombotic agent. 72
Trombocitopenia da eparina nel paziente dializzato 72
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. 70
Involvement of platelets in experimental mouse trypanosomiasis: evidence of mouse platelet cytotoxicity against Trypanosoma equiperdum. 69
NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. 68
Matrix metalloproteinase-2 on activated platelets triggers endothelial PAR-1 initiating atherosclerosis 68
Potentiation and priming of platelet activation: a potential target for antiplatelet therapy. 66
Platelets in respiratory disorders and inflammatory conditions. 63
Matrix Metalloproteinases and Platelet Function 63
Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. 62
Interactions of gallic acid, resveratrol, quercetin and aspirin at the platelet cyclooxygenase-1 level. Functional and modelling studies. 60
Platelets and chemotaxis. 58
Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway 58
Role of Platelets in the Pathogenesis of Osteoarthritis and Biological Effects of Hyaluronic Acid: in Vivo and in Vitro Study 56
The effect of defibrotide on thromboembolism in the pulmonary vasculature of mice and rabbits and in the cerebral vasculature of rabbits 54
PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention 53
Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis. 49
Stroke prevention: from available antiplatelet drugs to novel molecular targets. 49
Dicer Neosynthesis Regulates Platelet Reactivity: A Mechanism Altered in Type 2 Diabetes 48
Totale 5.665
Categoria #
all - tutte 26.199
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.199


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022495 0 110 12 26 9 10 7 147 7 19 69 79
2022/20231.002 70 232 10 71 78 104 0 48 338 3 30 18
2023/2024381 19 42 18 5 2 4 99 9 46 12 77 48
2024/2025768 6 78 34 28 107 37 29 56 157 32 142 62
2025/20261.886 117 116 111 231 282 161 336 72 209 137 92 22
2026/202776 35 41 0 0 0 0 0 0 0 0 0 0
Totale 5.665